Fanconi anemia (FA) and squamous cell carcinoma in childhood

International Journal of Pediatric Otorhinolaryngology

Volumn 70, Issue 11, 2006, Pages 1995-1997

  Aslan, Deniz ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BUTADIENE DIEPOXIDE; CISPLATIN; FLUOROURACIL; MITOMYCIN C;

BIOLOGICAL ACTIVITY; CANCER RISK; CHEMOTHERAPY; CHROMOSOME BREAKAGE; COAL MINING; CYTOTOXICITY; DISEASE COURSE; FANCONI ANEMIA; FATALITY; GENETIC DISORDER; HEAD AND NECK CARCINOMA; HISTOPATHOLOGY; HUMAN; LETTER; MUTATIONAL ANALYSIS; PASSIVE SMOKING; PRIORITY JOURNAL; RADIATION RESPONSE; SEX DIFFERENCE; SQUAMOUS CELL CARCINOMA; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT PLANNING;

CARCINOMA, SQUAMOUS CELL; CHILD; FANCONI ANEMIA; FEMALE; HUMANS; HYPOPHARYNGEAL NEOPLASMS; MALE;

EID: 33749560326     PISSN: 01655876     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijporl.2006.07.009     Document Type: Letter

References (14)

1. Köksal Y., Varan A., Hoşal S., and Büyükpamukçu M. Hypopharyngeal squamous cell carcinoma in a child. Int. J. Pediatr. Otorhinolaryngol. 69 (2005) 989-991
2. Sobeck A., Stone S., Costanzo V., de Graaf B., Reuter T., de Winter J., et al. Fanconi anemia proteins are required to prevent accumulation of replication-associated DNA double-strand breaks. Mol. Cell Biol. 26 (2006) 425-437
3. Levitus M., Joenje H., and de Winter J.P. The Fanconi anemia pathway of genomic maintenance. Cell Oncol. 28 (2006) 3-29
4. Alter B.P. Cancer in Fanconi anemia, 1927-2001. Cancer 97 (2003) 425-440
5. Rosenberg P.S., Grene M.H., and Alter B.P. Cancer incidence in persons with Fanconi anemia. Blood 101 (2003) 822-826
6. Singh B. Squamous cell carcinoma and FA. In: Owen J., Frohnmayer L., and Eiler M.E. (Eds). Fanconi Anemia Standards for Clinical Care (2003), Fanconi Anemia Research Fund, Oregon 137-150
7. Kutler D.I., Auerbach A.D., Satagopan J., Giampietro P.F., Batish S.D., Huvos A.G., et al. High incidence of head and neck squamous cell carcinoma in patients with Fanconi Anemia. Arch. Otolaryngol. Head Neck Surg. 129 (2003) 106-112
8. van Zeeburg H.J., Snijders P.J., Pals G., Hermsen M.A., Rooimans M.A., Bagby G., et al. Generation and molecular characterization of head and neck squamous cell lines of fanconi anemia patients. Cancer Res. 65 (2005) 1271-1276
9. Alter B.P., Joenje H., Oostra A.B., and Pals G. Fanconi anemia: adult head and neck cancer and hematopoietic mosaicism. Arch. Otolaryngol. Head Neck Surg. 131 (2005) 635-639
10. Alter B. Diagnostic evaluation of FA. In: Owen J., Frohnmayer L., and Eiler M.E. (Eds). Fanconi Anemia Standards for Clinical Care (2003), Fanconi Anemia Research Fund, Oregon 3-16
11. Huck K., Hanenberg H., Gudowius S., Fenk R., Kalb R., Neveling K., et al. Delayed diagnosis and complications of Fanconi anaemia at advanced age-a paradigm. Br. J. Haematol. 133 (2006) 188-197
12. Alter B.P. Radiosensitivity in Fanconi's anemia patients. Radiother. Oncol. 62 (2002) 345-347
13. Bremer M., Schindler D., Gross M., Dork T., Morlot S., and Karstens J.H. Fanconi's anemia and clinical radiosensitivity report on two adult patients with locally advanced solid tumors treated by radiotherapy. Strahlenther. Onkol. 179 (2003) 748-753
14. Marcou Y., D'Andrea A., Jeggo P.A., and Plowman P.N. Normal cellular radiosensitivity in an adult Fanconi anaemia patient with marked clinical radiosensitivity. Radiother. Oncol. 60 (2001) 75-79